UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052196
Receipt number R000059455
Scientific Title Practical open lung ventilation strategy in the low respiratory compliance cases
Date of disclosure of the study information 2023/09/14
Last modified on 2023/12/22 23:57:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Practical open lung ventilation strategy in the low respiratory compliance cases

Acronym

Quest for practical open lung ventilation strategy

Scientific Title

Practical open lung ventilation strategy in the low respiratory compliance cases

Scientific Title:Acronym

Quest for practical open lung ventilation strategy

Region

Japan


Condition

Condition

Anaesthesia in obese patients undergoing robot-assisted laparoscopic radical prostatectomy

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The pressure-controlled inverse ratio ventilation (PC-IRV) with I:E ratio of 3:1-4:1 under PEEP off reduces physiological dead space effectively. However, PC-IRV with I:E ratio of 3:1-4:1 under PEEP off has a potential risk of hyper-inflation.
We hypothesized that PC-IRV with I:E ratio of 1:1-2:1 under PEEP 5 cmH2O would become a practical and safe open lung ventilation strategy in low respiratory compliance situations.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

physiological dead space during ventilation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Using respiratory ventilation (Engstrom Caredtation, GE Healthcare), interventions start after Trendelenburg position and pneumoperitoneum were established. Using PC-VG mode, the target volume is set to 6 -8 ml/kg of ideal body weight. Respiratory rate is set to 12 bpm.

Control; I:E ratio of 1:2, PEEP of 5 cmH2O for 30 min.

Interventions/Control_2

Conventional PC-IRV; I:E ratio of 4:1, PEEP of 0 cmH2O for 30 min.

Interventions/Control_3

Practical PC-IRV; I:E ratio of 1.5:1, PEEP 5 cmH2O, for 30 min.

Interventions/Control_4

High PEEP strategy; I:E ratio of 1:2, PEEP 10 cmH2O, for 30 min.

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

75 years-old >

Gender

Male

Key inclusion criteria

The study included patients with BMI >25 kg/m2 scheduled to undergo robot-assisted laparoscopic radical prostatectomy.

Key exclusion criteria

The exclusion criteria were ASA physical status of 3-5, a history of asthma, pulmonary emphysema, pneumothorax, or lung surgery.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Go
Middle name
Last name Hirabayashi

Organization

Mizonokuchi Hospital, Teikyo University School of Medicine

Division name

Anesthesiology

Zip code

213-8507

Address

5-1-1 Futako Takatsu-Ku Kawasaki Kanagawa

TEL

+81448443333

Email

goh@med.teikyo-u.ac.jp


Public contact

Name of contact person

1st name Go
Middle name
Last name Hirabayashi

Organization

Mizonokuchi Hospital, Teikyo University School of Medicine

Division name

Anesthesiology

Zip code

213-8507

Address

5-1-1 Futako Takatsu-Ku Kawasaki Kanagawa

TEL

+81448443333

Homepage URL


Email

goh@med.teikyo-u.ac.jp


Sponsor or person

Institute

Mizonokuchi Hospital, Teikyo University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Mizonokuchi Hospital, Teikyo University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical trial office, Teikyo University School of Medicine

Address

2-11-1 Kaga Itabashi-Ku Tokyo

Tel

03-3964-9358

Email

chiken@med.teikyo-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 09 Month 12 Day

Date of IRB

2023 Year 09 Month 12 Day

Anticipated trial start date

2023 Year 09 Month 19 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 09 Month 13 Day

Last modified on

2023 Year 12 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059455